共 50 条
- [41] Decision-making of adjuvant therapy in pT1N1M0 gastric cancer: Should radiotherapy be added to chemotherapy? A propensity score-matched analysis JOURNAL OF CANCER, 2021, 12 (04): : 1179 - 1189
- [42] Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: A propensity-matched analysis JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (02): : 743 - +
- [48] EFFECT OF NEOADJUVANT CHEMOTHERAPY IN IMPROVING OVERALL SURVIVAL OF T2-4AN0M0 BLADDER CANCER PATIENTS: A SYSTEMIC REVIEW AND META-ANALYSIS ACCORDING TO EAU COVID-19 RECOMMENDATION JOURNAL OF UROLOGY, 2022, 207 (05): : E382 - E383
- [50] Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (03): : 248 - 256